Sunday, January 22, 2023 10:43:16 AM
BY Canada NewsWire
— 2:35 PM ET 01/19/2023
TSX.V: DME
U.S. OTC: DMEHF
Frankfurt: QM01
VANCOUVER, BC, Jan. 19, 2023 /CNW/ - DESERT MOUNTAIN ENERGY CORP. (DMEHF) (the "Company") , (U.S. OTC: DMEHF), From the President of the Company. The Company is pleased to announce that on January 17, 2023, the Company held a commissioning ceremony for the McCauley Helium Processing Facility. A ribbon-cutting ceremony was performed by Robert Rohlfing, CEO and Executive Director of DME. The Company's management, directors, legal and accounting along with the McCauley Family and members of the investment community were in attendance.
All attendees at the commissioning of the McCauley Helium Processing Facility. (CNW Group/Desert Mountain Energy Corp.)
"Over twenty years of hard work and planning came to fruition as we opened the doors for attendees to walk through the first-of-its-kind helium processing facility," said Robert Rohlfing, CEO of DME. "We look forward to the start of testing this month prior to initiating the 90-day optimization program that will lead into full commercial production."
The 8 acres of solar panels have now been rolled out in addition to the onsite necessary infrastructure being near completion and the interconnects linking the modular units are being completed. All road work and over a mile of fencing are complete.
ABOUT DESERT MOUNTAIN ENERGY (DMEHF)
Desert Mountain Energy Corp. (DMEHF) is a publicly traded resource company primarily focused on exploration, development and production of helium, hydrogen and noble gases. The Company is primarily looking for elements deemed critical to the renewable energy and high technology industries.
We seek safe harbor
"Robert Rohlfing"
Robert Rohlfing
Exec Chairman & CEO
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in polices of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. The statements made in this press release may contain certain forward-looking statements that involve a number of risks and uncertainties. Actual events or results may differ from the Company's expectations.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM